head and neck cancer Clinical Trials and Research
Also known as: oral cancer, throat cancer, laryngeal cancer, pharyngeal cancer, salivary gland cancer, sinus cancer · ICD-10: C00-C32
Head and neck cancer refers to a group of cancers originating in the mouth, throat, voice box, or other areas of the head and neck. Clinical trial research aims to discover new therapies, improve diagnostic methods, and enhance patient quality of life. Find a Trial helps patients search active studies.
Search head and neck cancer trials →
Common questions about head and neck cancer clinical trials
Who can participate in head and neck cancer clinical trials?
Eligibility criteria vary by study, often including cancer type, stage, prior treatments, and overall health. Researchers use these criteria to ensure patient safety and gather meaningful data. Information is available on ClinicalTrials.gov.
What are the different phases of clinical trials for head and neck cancer?
Clinical trials progress through phases 1, 2, and 3, each with specific goals, like testing safety, efficacy, and comparing new treatments to standard care. Phase 4 studies occur after a treatment is approved. Details can be found on ClinicalTrials.gov.
Do clinical trials for head and neck cancer cost money to participate?
Generally, study-related medical costs, such as experimental treatments and tests, are covered by the trial sponsor. However, routine medical care costs and non-medical expenses like travel may not be. Patients should discuss this with the study team.
What are current research directions for head and neck cancer treatments?
Current research, as seen on ClinicalTrials.gov and NIH RePORTER, focuses on immunotherapy, targeted therapies, improved radiation techniques, and combination approaches. Scientists are also exploring ways to reduce treatment side effects and prevent recurrence.
What types of interventions are commonly studied in head and neck cancer trials?
Common interventions include new chemotherapy drugs, radiation therapy techniques, surgical approaches, immunotherapy agents, and targeted therapies. Studies also investigate supportive care to manage side effects and improve recovery, according to ClinicalTrials.gov.
Are there specific biomarkers relevant to head and neck cancer clinical trials?
Yes, biomarkers like HPV status, PD-L1 expression, and specific genetic mutations are often studied to predict treatment response or guide therapy. Research on these and other markers helps personalize treatment approaches, as noted on NIH RePORTER.
What might prevent someone from joining a head and neck cancer trial?
Common exclusion criteria can include certain prior treatments, other serious medical conditions, or specific cancer stages not relevant to the study. These criteria help ensure patient safety and the study's scientific integrity, per ClinicalTrials.gov.
Are there clinical trials focused on improving quality of life for head and neck cancer patients?
Absolutely. Many trials, visible on ClinicalTrials.gov and NIH RePORTER, investigate interventions to manage side effects like difficulty swallowing or speaking, pain, and fatigue. These studies aim to enhance overall well-being during and after treatment.
How to find a head and neck cancer trial that fits you
- Describe your head and neck cancer situation in detail — stage if applicable, prior treatments, age, and other relevant conditions.
- Use the location filter (worldwide, US, US & Canada, Europe) to narrow to trials near you.
- Review each trial's eligibility criteria carefully. Save 2–5 candidates with their NCT numbers.
- Discuss with your treating clinician before contacting the research site.
Browse all head and neck cancer trials →